Lack of gender differences in neuroleptic response in patients with schizophrenia

Schizophrenia Research

Volumn 22, Issue 3, 1996, Pages 215-222

  Pinals, Debra A ^a   Malhotra, Anil K ^a   Missar, C David ^a   Pickar, David ^a   Breier, Alan ^a  

^a NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

gender; neuroleptic treatment; schizophrenia; sex differences

Indexed keywords

CHLORPROMAZINE; FLUPHENAZINE; NEUROLEPTIC AGENT; PIMOZIDE; THIORIDAZINE; TRIFLUOPERAZINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG RESPONSE; FEMALE; GENDER; HUMAN; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SEX CHARACTERISTICS;

EID: 0030589496     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0920-9964(96)00067-9     Document Type: Article

References (28)

1. Angermeyer, M.C., Kuhn, L. and Goldstein, J.M. (1990) Gender and the course of schizophrenia: differences in treated outcomes. Schizophr. Bull. 16, 293-307.
2. Castle, D.J. and Murray, R.M. (1991) The neurodevelopmental basis of sex differences in schizophrenia. Psychol. Med. 21, 565-575.
3. Castle, D.J., Wessely, S. and Murray, R.M. (1993) Sex and schizophrenia: Effects of diagnostic stringency, and associations with premorbid variables. Br. J. Psychiatry 162, 658-664.
4. Childers, S.E. and Harding, C.M. (1990) Gender, premorbid social functioning, and long-term outcome in DSM-III schizophrenia. Shizophr. Bull. 18, 309-318.
5. Chouinard, G. and Annable, L. (1982) Pimozide in the treatment of newly admitted schizophrenic patients. Psychopharmacology 76, 13-19.
6. Glick, M., Mazure, C.M., Bowers, M.B. and Zigler, E. (1993) Premorbid social competence and the effectiveness of early neuroleptic treatment. Compr. Psychiatry 34, 396-401.
7. Goldberg, S.C., Schooler, N.R., Davidson, E.M. and Kayce, M.M. (1966) Sex and race differences in response to drug treatment among schizophrenics. Psychopharmacologia 9, 31-47.
8. Goldstein, J.M. (1988) Gender differences in the course of schizophrenia. Am. J. Psychiatry 145, 684-689.
9. Goldstein, J.M., Tsuang, M.T. and Faraone, S.V. (1989) Gender and schizophrenia: implications for understanding the heterogeneity of the illness. Psychiatry Res. 28, 243-253.
10. Goldstein, M.J., Rodnick, E.H., Evans, J.R. et al. (1978) Drug and family therapy in the aftercare of acute schizophrenics. Arch. Gen. Psychiatry 35, 1169-1177.
11. Gureje, O. (1991) Gender and schizophrenia: age at onset and sociodemographic attributes. Acta. Psychiatr. Scand. 83, 402-405.
12. Haas, G.L., Glick, I.D., Clarkin, J.F. et al. (1990) Gender and schizophrenia outcome: a clinical trial of an inpatient family intervention. Schizophr. Bull. 16, 277-292.
13. Hambrecht, M., Maurer, K. and Hafner, H. (1992) Transnational stability of gender differences in schizophrenia? An analysis based on the WHO study on Determinants of Outcome of Severe Mental Disorders. Eur. Arch. Psychiatry Clin. Neurosci. 242, 6-12.
14. Hogarty, G.E., Goldberg, S.C., Schooler, N.R., Ulrich, R.F. and the Collaborative Group (1974) Drug and sociotherapy in the aftercare of schizophrenic patients. II. Two year relapse rates. Arch. Gen. Psychiatry 31, 603-618.
15. Jeste, D.V., Kleinman, J.E., Potkin, S.G. et al. (1982) Ex Uno Multi: subtyping the schizophrenic syndrome. Biol. Psychiatry 17, 199-222.
16. Kaplan, H.I. and Sadock, B.J. (1993) Pocket Handbook of Psychiatric Drug Treatment, Williams and Wilkins, Baltimore, MD, pp. 110-111.
17. Kolakowska, T., Williams, A.O., Ardern, M. et al. (1985) Schizophrenia with good and poor outcome I: early clinical features, response to neuroleptics and signs of organic dysfunction. Br. J. Psychiatry 146, 229-246.
18. Meltzer, H.Y., Busch, D.A. and Fang, V.S. (1983) Serum neuroleptic and prolactin levels in schizophrenic patients and clinical response. Psychiatry Res. 9, 271-283.
19. Overall, J.E. and Gorham, D.E. (1961) The Brief Psychiatric Rating Scale. Psychol. Rep. 10, 799-812.
20. Phillips, L. (1953) Case history data and prognosis in schizophrenia. J. Nerv. Ment. Dis. 17, 515-525.
21. Plocka, M. and Rybakowski, J. (1992) [Gender differences in schizophrenia] Salokangas, R.K.R. and Stengard, E. (1990) Gender and short-term outcome in schizophrenia. Schizophr. Res. 3, 333-345.
22. Plocka, M. and Rybakowski, J. (1992) [Gender differences in schizophrenia] Salokangas, R.K.R. and Stengard, E. (1990) Gender and short-term outcome in schizophrenia. Schizophr. Res. 3, 333-345.
23. Salokangas, R.K.R. (1995) Gender and the use of neuroleptics in schizophrenia: further testing of the oestrogen hypothesis. Schizophr. Res. 3, 333-345.
24. Seeman, M.V. (1982) Gender differences in schizophrenia. Can. J. Psychiatry. 27, 107-111.
25. Seeman, M.V. (1983) Interaction of sex, age, and neuroleptic dose. Compr. Psychiatry 24, 125-128.
26. Seeman, M.V. (1986) Current outcome in schizophrenia: women vs. men. Acta Psychiatr. Scand. 73, 609-617.
27. Szymanski, S., Lieberman, J.A., Alvir, J.M. et al. (1995) Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. Am. J. Psychiatry 152, 698-703.
28. Young, M.A. and Meltzer, H.Y. (1980) The Relationship of demographic, clinical, and outcome variables to neuroleptic treatment requirements. Schizophr. Bull. 6, 88-101.